592 related articles for article (PubMed ID: 19219686)
1. Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
Hosseini H; Mehryar M; Eghtedari M; Ahmadi F; Nowroozizadeh S
Curr Eye Res; 2009 Feb; 34(2):145-51. PubMed ID: 19219686
[TBL] [Abstract][Full Text] [Related]
2. Effect of intravitreal triamcinolone acetonide on susceptibility to experimental bacterial endophthalmitis and subsequent response to treatment.
Bucher RS; Hall E; Reed DM; Richards JE; Johnson MW; Zacks DN
Arch Ophthalmol; 2005 May; 123(5):649-53. PubMed ID: 15883284
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin.
Ozkiriş A; Evereklioglu C; Eşel D; Akgün H; Erkiliç K
Ophthalmic Res; 2005; 37(3):168-74. PubMed ID: 15942265
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis.
De Kaspar HM; Ta CN; Engelbert M; Mette M; Thiel M; Kampik A
Retina; 2008 Feb; 28(2):326-32. PubMed ID: 18301039
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
Deng SX; Penland S; Gupta S; Fiscella R; Edward DP; Tessler HH; Goldstein DA
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1516-21. PubMed ID: 16565387
[TBL] [Abstract][Full Text] [Related]
6. A comparison of intravitreal piperacillin/tazobactam with ceftazidime in experimental Pseudomonas aeruginosa endophthalmitis.
Ozkiriş A; Evereklioglu C; Akgün H; Eşel D; Caner F; Erkiliç K
Exp Eye Res; 2005 Mar; 80(3):361-7. PubMed ID: 15721618
[TBL] [Abstract][Full Text] [Related]
7. Effect of caffeic acid phenethyl ester on treatment of experimentally induced methicillin-resistant Staphylococcus epidermidis endophthalmitis in a rabbit model.
Yildirim O; Yilmaz A; Oz O; Vatansever H; Cinel L; Aslan G; Tamer L; Adigüzel U; Arpaci R; Kanik A; Emekdaş G
Cell Biochem Funct; 2007; 25(6):693-700. PubMed ID: 16981209
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of intravitreal vancomycin and dexamethasone in the treatment of experimental bacillus cereus endophthalmitis.
Liu F; Kwok AK; Cheung BM
Curr Eye Res; 2008 Sep; 33(9):761-8. PubMed ID: 18798079
[TBL] [Abstract][Full Text] [Related]
10. Intravitreal taurolidine against experimental Staphylococcus epidermidis endophthalmitis in rabbits.
Oguz H; Zeyrek FY; Ozardali I; Oguz E; Gurkan T
Curr Eye Res; 2004 Apr; 28(4):225-32. PubMed ID: 15259291
[TBL] [Abstract][Full Text] [Related]
11. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
12. Intravenous imipenem prophylaxis in experimental endophthalmitis.
Miño de Kaspar H; Engelbert M; Thiel M; Grasbon T; Ta CN; Klauss V; Kampik A
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):557-64. PubMed ID: 12136287
[TBL] [Abstract][Full Text] [Related]
13. Effect of blood on susceptibility to Staphylococcal endophthalmitis.
Wells EJ; Franco LM; Price CT; Graham JE; Barr CC
Retina; 2007 Oct; 27(8):1125-30. PubMed ID: 18040257
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Ferrer C; Rodríguez A; Abad JL; Fernandez J; Alió JL
Br J Ophthalmol; 2008 May; 92(5):678-82. PubMed ID: 18211926
[TBL] [Abstract][Full Text] [Related]
15. Immune response to Staphylococcus epidermidis-induced endophthalmitis in a rabbit model.
Pleyer U; Mondino BJ; Adamu SA; Pitchekian-Halabi H; Engstrom RE; Glasgow BJ
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2650-63. PubMed ID: 1639612
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis.
Meredith TA; Trabelsi A; Miller MJ; Aguilar E; Wilson LA
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):181-6. PubMed ID: 2298537
[TBL] [Abstract][Full Text] [Related]
17. High dose intramuscular methylprednisolone in experimental Staphylococcus aureus endophthalmitis.
Yoshizumi MO; Kashani A; Palmer J; Lee G; Mondino B
J Ocul Pharmacol Ther; 1999 Feb; 15(1):91-6. PubMed ID: 10048352
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental Bacillus cereus endophthalmitis using intravitreal moxifloxacin with or without dexamethasone.
Sakalar YB; Ozekinci S; Celen MK
J Ocul Pharmacol Ther; 2011 Dec; 27(6):593-8. PubMed ID: 21834669
[TBL] [Abstract][Full Text] [Related]
19. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal trovafloxacin against experimental Staphylococcus epidermidis endophthalmitis.
Karaküçük S; Mirza E; Sümerkan B; Okten T
Ophthalmic Res; 2000; 32(2-3):126-31. PubMed ID: 10754446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
